Cite

HARVARD Citation

    Chaudhry, M. et al. (2019). Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström's macroglobulinemia. Leukemia & lymphoma. 60 (4), pp. 964-970. [Online]. 
  
Back to record